Clinical Trial Update: DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of DPPE in combination with Epirubicin and Cyclophosphamide for breast cancer with metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DPPE
• Epirubicin (epirubicin)

Snippet

Sponsor: YM BioSciences | Conditions: Breast Cancer, Metastases | Phase 3 | Status: TERMINATED